🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 18 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/10/2021 | 189,65 | 189,85 | 185,70 | 186,14 | -2,26% | 2,19% | 656.900 |
| 26/10/2021 | 192,00 | 192,00 | 189,25 | 190,45 | -0,47% | 1,43% | 345.100 |
| 25/10/2021 | 191,70 | 193,19 | 189,72 | 191,34 | +0,17% | 1,81% | 504.100 |
| 22/10/2021 | 190,14 | 192,58 | 189,67 | 191,01 | +0,18% | 1,53% | 197.900 |
| 21/10/2021 | 193,42 | 194,08 | 189,18 | 190,66 | -0,84% | 2,53% | 226.800 |
| 20/10/2021 | 189,94 | 194,22 | 189,18 | 192,27 | +3,17% | 2,65% | 437.600 |
| 19/10/2021 | 184,81 | 187,00 | 182,38 | 186,36 | +1,11% | 2,50% | 279.700 |
| 18/10/2021 | 183,65 | 185,34 | 180,25 | 184,32 | -1,47% | 2,77% | 632.500 |
| 15/10/2021 | 187,93 | 188,30 | 184,31 | 187,07 | -0,28% | 2,12% | 341.400 |
| 14/10/2021 | 186,28 | 189,50 | 185,10 | 187,60 | +0,81% | 2,36% | 261.900 |
| 13/10/2021 | 190,88 | 191,87 | 185,66 | 186,09 | -2,02% | 3,25% | 247.800 |
| 12/10/2021 | 193,81 | 194,45 | 188,22 | 189,93 | -1,61% | 3,21% | 357.800 |
| 11/10/2021 | 194,13 | 195,70 | 192,36 | 193,04 | -1,20% | 1,72% | 373.700 |
| 08/10/2021 | 195,32 | 199,65 | 193,81 | 195,38 | -0,29% | 2,99% | 478.100 |
| 07/10/2021 | 192,26 | 196,74 | 189,33 | 195,94 | +2,17% | 3,85% | 381.800 |
| 06/10/2021 | 187,62 | 191,99 | 185,64 | 191,77 | +1,60% | 3,38% | 384.300 |
| 05/10/2021 | 185,52 | 191,37 | 184,24 | 188,75 | +1,82% | 3,84% | 401.900 |
| 04/10/2021 | 184,63 | 186,57 | 183,09 | 185,37 | -0,29% | 1,88% | 337.600 |
| 01/10/2021 | 184,64 | 187,94 | 178,41 | 185,90 | +0,72% | 5,16% | 354.400 |
| 30/09/2021 | 186,07 | 187,15 | 184,04 | 184,58 | -0,50% | 1,67% | 312.600 |
| 29/09/2021 | 188,16 | 188,76 | 180,92 | 185,50 | -1,15% | 4,17% | 471.700 |
| 28/09/2021 | 193,77 | 195,92 | 186,80 | 187,66 | -3,90% | 4,71% | 479.100 |
| 27/09/2021 | 195,44 | 200,27 | 194,33 | 195,28 | +0,09% | 3,04% | 453.000 |
| 24/09/2021 | 199,26 | 200,05 | 194,52 | 195,10 | -2,68% | 2,78% | 214.600 |
| 23/09/2021 | 201,92 | 203,49 | 199,85 | 200,47 | -0,72% | 1,80% | 182.100 |
| 22/09/2021 | 199,46 | 202,50 | 196,39 | 201,92 | +1,55% | 3,06% | 162.900 |
| 21/09/2021 | 198,79 | 200,93 | 198,13 | 198,83 | +0,16% | 1,41% | 221.000 |
| 20/09/2021 | 198,24 | 200,23 | 196,97 | 198,51 | -0,78% | 1,64% | 311.300 |
| 17/09/2021 | 204,98 | 204,98 | 199,06 | 200,08 | -2,47% | 2,89% | 591.300 |
| 16/09/2021 | 204,27 | 207,14 | 202,51 | 205,14 | +0,43% | 2,27% | 248.300 |